Search research articles
Contact Us
Filters
Showing results (951-960 of 969) with videos related to
Page
of 97
Sort By:
Cancer Immunology, Immunotherapy : CII
|
August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Cancer Research
|
March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection
Andrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Journal of Medicinal Chemistry
|
December 12, 2017
Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei, Janet Gunzner-Toste, Hui Yao, et al.
Journal of Medicinal Chemistry
|
February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma
Xiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Molecular Cancer Therapeutics
|
February 23, 2017
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers
Thomas H Pillow, Melissa Schutten, Shang-Fan Yu, et al.
Chemmedchem
|
November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
Thomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Nature Biotechnology
|
January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen, Keyang Xu, Luna Liu, et al.
Lancet (London, England)
|
July 18, 2017
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell, Jean Bennett, Jennifer A Wellman, et al.
Surgical Neurology
|
October 13, 2009
Clinical practice guidelines in severe traumatic brain injury in Taiwan
Kuo-Hsing Liao, Cheng-Kuei Chang, Hong-Chang Chang, et al.
Molecular Pharmaceutics
|
July 25, 2018
Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates
Zhonghua Pei, Chunjiao Chen, Jinhua Chen, et al.
Page
of 97
Search research articles
Search
Showing results (951-960 of 969) with videos related to
Sort By:
Page
of 97
Cancer Immunology, Immunotherapy : CII
|
August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity
Aurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.
Cancer Research
|
March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection
Andrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Journal of Medicinal Chemistry
|
December 12, 2017
Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei, Janet Gunzner-Toste, Hui Yao, et al.
Journal of Medicinal Chemistry
|
February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma
Xiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Molecular Cancer Therapeutics
|
February 23, 2017
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers
Thomas H Pillow, Melissa Schutten, Shang-Fan Yu, et al.
Chemmedchem
|
November 2, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
Thomas H Pillow, Pragya Adhikari, Robert A Blake, et al.
Nature Biotechnology
|
January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen, Keyang Xu, Luna Liu, et al.
Lancet (London, England)
|
July 18, 2017
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen Russell, Jean Bennett, Jennifer A Wellman, et al.
Surgical Neurology
|
October 13, 2009
Clinical practice guidelines in severe traumatic brain injury in Taiwan
Kuo-Hsing Liao, Cheng-Kuei Chang, Hong-Chang Chang, et al.
Molecular Pharmaceutics
|
July 25, 2018
Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates
Zhonghua Pei, Chunjiao Chen, Jinhua Chen, et al.
Page
of 97